Philip Morris: Transitioning from Cigarettes to Smoke-Free Products

Company Profile of Philip Morris International

Philip Morris International (PM) is a global manufacturer of cigarettes, e-cigarettes, heated tobacco products, and oral nicotine products, operating in over 180 countries. The company was spun off from the Altria Group in early 2008 and initially focused on premium cigarette brands, including Marlboro, Parliament, and Virginia Slims. Although cigarettes continue to be a major revenue driver, Philip Morris is diversifying into non-cigarette products.

Surge in Zyn Smoke-Free Business

Recognizing the growing consumer preference for health-conscious alternatives, Philip Morris has entered the smoke-free market with Zyn, a highly successful oral nicotine pouch. This product aligns with a broader trend as consumers seek alternatives to traditional tobacco.

Zyn’s popularity has soared, largely driven by its viral presence on TikTok, capturing approximately 75% of the tobacco pouch market. Younger consumers are particularly attracted to these pouches, which provide a less harmful method of nicotine delivery compared to smoking. Additionally, while nicotine can be addictive, research suggests it may have beneficial effects, such as enhancing focus. Shipments of Zyn have increased over five times in the past five years, and growth is projected to continue.

Philip Morris: Consistent Growth and Solid Performance

Philip Morris may not show the high double-digit earnings growth typical of growth stocks. However, its steadiness and reliability are noteworthy. Over the last three quarters, the company’s earnings per share (EPS) grew by 14%, 14%, and 13% year-over-year. Moreover, annual earnings have steadily increased over the past three years.

Image Source: Zacks Investment Research

This stability is also evident in PM’s stock performance, which is reflected in its beta of 0.14—indicating significantly lower volatility compared to the S&P 500 Index. Remarkably, PM has outperformed 95% of stocks in the S&P 500.

Image Source: Zacks Investment Research

Consistent Performance Against Analyst Expectations

Philip Morris has exceeded Zacks Consensus Analyst Estimates in 19 of the last 20 quarters, highlighting its strong operational capabilities.

Image Source: Zacks Investment Research

Should this trend persist, analysts predict double-digit EPS growth through 2026. The company also has low operating costs and a robust cash position, which further supports its financial health.

Conclusion

Philip Morris is effectively transforming its business model beyond traditional cigarette sales, marked by the impressive success of its Zyn oral nicotine pouches.